Nutr Res Pract.  2018 Aug;12(4):291-297. 10.4162/nrp.2018.12.4.291.

Effects of Schisandra chinensis fruit extract and gomisin A on the contractility of penile corpus cavernosum smooth muscle: a potential mechanism through the nitric oxide - cyclic guanosine monophosphate pathway

Affiliations
  • 1Department of Urology, Chonbuk National University and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University, 567, Baekje-daero, Deokjin-gu, Jeonju-si, Jeonbuk 54896, Korea. rain@chonbuk.ac.kr
  • 2College of Pharmacy, Kyungsung University, Busan 48434, Korea.

Abstract

BACKGROUND/OBJECTIVES
This study evaluated the effects and molecular mechanisms of the Schisandra chinensis fruit extract (SC) and its major compound gomisin A (GA), on the contractility of rabbit penile corpus cavernosum smooth muscle (PCCSM).
MATERIALS/METHODS
PCCSM was exposed to SC or GA after appropriate pretreatment with nitric oxide synthase (NOS) blocker, guanylate cyclase blocker, adenylyl cyclase blocker or protein kinase A blocker. Subsequently, we evaluated the cyclic nucleotide in the perfusate by radioimmunoassay, protein expression level of neuronal NOS (nNOS) and endothelial NOS (eNOS) by western blot, and the interaction of SC or GA with udenafil and rolipram.
RESULTS
Both SC and GA induce PCCSM relaxations in a concentration-dependent manner. Pretreatment with NOS blocker, guanylate cyclase blocker, adenylyl cyclase blocker or protein kinase A blocker result in significantly decreased relaxation. SC and GA also induce the levels of cyclic nucleotide in the perfusate in a concentration-dependent manner. Perfusion with GA also showed significantly higher levels of eNOS protein. Furthermore, the udenafil and rolipram induced relaxations of PCCSM were enhanced after exposure to SC and GA. Our results indicate that SC and GA induce the relaxation of PCCSM via the nitric oxide (NO)-cGMP and cAMP signaling pathways.
CONCLUSIONS
The SC and GA are potential alternative treatments for men who want to consume natural products to ameliorate erectile function, or who do not respond to the commercially available medicines.

Keyword

Nitric oxide; lignans; erectile dysfunction; PDE5 inhibitors

MeSH Terms

Adenylyl Cyclases
Biological Products
Blotting, Western
Cyclic AMP-Dependent Protein Kinases
Erectile Dysfunction
Fruit*
Guanosine Monophosphate*
Guanosine*
Guanylate Cyclase
Humans
Lignans
Male
Muscle, Smooth*
Neurons
Nitric Oxide Synthase
Nitric Oxide*
Perfusion
Phosphodiesterase 5 Inhibitors
Radioimmunoassay
Relaxation
Rolipram
Schisandra*
Adenylyl Cyclases
Biological Products
Cyclic AMP-Dependent Protein Kinases
Guanosine
Guanosine Monophosphate
Guanylate Cyclase
Lignans
Nitric Oxide
Nitric Oxide Synthase
Phosphodiesterase 5 Inhibitors
Rolipram

Figure

  • Fig. 1 Relaxation effect of SC in Phe-induced contraction (n = 4). PCCSM contracted by Phe (10−5 M) was pretreated with ODQ (A, 10−5 M), L-NAME (B, 10−3 M), MDL 12330A (C, 10−5 M) or H-89(D, 10−4 M), and subsequently exposed to four concentrations of SC (0.1, 0.5, 1 and 2 mg/mL). SC: Schisandra chinensis; Phe: L-phenylephrine; PCCSM: penile corpus cavernosum smooth muscle; ODQ: 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one; L-NAME: Nω-Nitro-L-arginine methyl ester hydrochloride; MDL 12330A: MDL 12330A hydrochloride; H-89: H-89 dihydrochloride hydrate. Values are mean ± SD. *,**Statistically significant from SC. *P < 0.05, **P < 0.01.

  • Fig. 2 Relaxation effect of GA in Phe-induced contraction (n = 4). PCCSM contracted by Phe (10−5 M) was pretreated with ODQ (A, 10−5 M), L-NAME (B, 10−3 M), MDL 12330A (C, 10−5 M) or H-89(D, 10−4 M), and subsequently exposed to four concentrations of GA (10−7, 10−6, 10−5 and 10−4 M). GA: gomisin A; Phe: L-phenylephrine; PCCSM: penile corpus cavernosum smooth muscle; ODQ: 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one; L-NAME: Nω-Nitro-L-arginine methyl ester hydrochloride; MDL 12330A: MDL 12330A hydrochloride; H-89: H-89 dihydrochloride hydrate. Values are mean ± SD. *,**Statistically significant from GA. *P < 0.05, **P < 0.01.

  • Fig. 3 Effects of L-NAME (10−3 M) in SC (A, 1 mg/mL) or GA (B, 10−5 M) induced eNOS and nNOS protein in the PCCSM by western blotting (n = 4). L-NAME: Nω-Nitro-L-arginine methyl ester hydrochloride; SC: Schisandra chinensis; GA: gomisin A; eNOS: endothelial nitric oxide synthase; nNOS: neuronal nitric oxide synthase; PCCSM: penile corpus cavernosum smooth muscle. Values are mean ± SD. *Statistically significant from GA, P < 0.05.

  • Fig. 4 Interaction of SC (1 mg/mL) with UDE (10−7 M) or Rol (10−6 M) (n = 4). SC: Schisandra chinensis; UDE: udenafil; Rol: rolipram; UDE + SC: SC induced relaxation in the UDE-pretreated PCCSM (A); SC + UDE: UDE induced relaxation in the SC-pretreated PCCSM (A); Rol + SC: SC induced relaxation in the Rol-pretreated PCCSM (B); SC + Rol: Rol induced relaxation in the SC-pretreated PCCSM (B). Values are mean ± SD. **Statistically significant from Ude or Rol, P < 0.01.

  • Fig. 5 Interaction of GA (10−5 M) with UDE (10−7 M) or Rol (10−6 M) (n = 4). GA: gomisin A; UDE: udenafil; Rol: rolipram; UDE + GA: GA induced relaxation in the UDE-pretreated PCCSM (A); GA + UDE: UDE induced relaxation in the GA-pretreated PCCSM (A); Rol + GA: GA induced relaxation in the Rol-pretreated PCCSM (B); GA + Rol: Rol induced relaxation in the GA-pretreated PCCSM (B). Values are mean ± SD. **Statistically significant from Ude or Rol, P < 0.01.


Reference

1. Panossian A, Wikman G. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol. 2008; 118:183–212.
Article
2. He XG, Lian LZ, Lin LZ. Analysis of lignan constituents from Schisandra chinensis by liquid chromatography-electrospray mass spectrometry. J Chromatogr. 1997; 757:81–87.
Article
3. Kim EY, Baek IH, Rhyu MR. Cardioprotective effects of aqueous Schizandra chinensis fruit extract on ovariectomized and balloon-induced carotid artery injury rat models: effects on serum lipid profiles and blood pressure. J Ethnopharmacol. 2011; 134:668–675.
Article
4. Hikino H, Kiso Y, Taguchi H, Ikeya Y. Antihepatotoxic actions of lignoids from Schizandra chinensis fruits. Planta medica. 1984; 50:213–218.
5. Hu D, Cao Y, He R, Han N, Liu Z, Miao L, Yin J. Schizandrin, an antioxidant lignan from Schisandra chinensis, ameliorates Aβ1-42-induced memory impairment in mice. Oxid Med Cell Longev. 2012; 2012:721721.
6. Kang S, Lee KP, Park SJ, Noh DY, Kim JM, Moon HR, Lee YG, Choi YW, Im DS. Identification of a novel anti-inflammatory compound, α-cubebenoate from Schisandra chinensis. J Ethnopharmacol. 2014; 153:242–249.
Article
7. Han DH, Lee JH, Kim H, Ko MK, Chae MR, Kim HK, So I, Jeon JH, Park JK, Lee SW. Effects of Schisandra chinensis extract on the contractility of corpus cavernosal smooth muscle (CSM) and Ca2+ homeostasis in CSM cells. BJU Int. 2012; 109:1404–1413.
Article
8. Liu W, Choi BR, Bak YO, Zhang LT, Zhou LX, Huang YR, Zhao C, Park JK. Cavernosum smooth muscle relaxation induced by Schisandrol A via the NO-cGMP signaling pathway. Cell Mol Biol. 2016; 62:115–119.
9. Wespes E, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y. Guidelines on erectile dysfunction. Eur Urol. 2002; 41:1–5.
Article
10. Cho YJ, Hwang HS, Park HK, Jeong JG. Prevalence of erectile dysfunction and utilization of sexual counseling in community family medicine clinics. Korean J Fam Med. 2009; 30:617–625.
Article
11. Lee JH, Choi JK, Kim SH, Cho KH, Kim YT, Choi SH, Jung UW. Association between periodontal flap surgery for periodontitis and vasculogenic erectile dysfunction in Koreans. J Periodontal Implant Sci. 2017; 47:96–105.
Article
12. Ghalayini IF. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility. Int J Impot Res. 2004; 16:459–469.
Article
13. Paul V, Ekambaram P. Involvement of nitric oxide in learning & memory processes. Indian J Med Res. 2011; 133:471–478.
14. Nunes KP, Webb RC. Mechanisms in erectile function and dysfunction: an overview. erectile dysfunction-disease-associated mechanisms and novel insights into therapy. InTech;2012. p. 4–10.
15. Toque HA, Caldwell RW. New approaches to the design and discovery of therapies to prevent erectile dysfunction. Expert Opin Drug Discov. 2014; 9:1447–1469.
Article
16. Recio P, López PG, Hernández M, Prieto D, Contreras J, Garcí a-Sacristán A. Nitrergic relaxation of the horse corpus cavernosum. Role of cGMP. Eur J Pharmacol. 1998; 351:85–94.
Article
17. Zhang G, Liu Y, Ruoho AE, Hurley JH. Structure of the adenylyl cyclase catalytic core. Nature. 1997; 386:247–253.
Article
18. Rhyu M, Kim EY, Yoon BK, Lee Y, Chen SN. Aqueous extract of Schizandra chinensis fruit causes endothelium-dependent and-independent relaxation of isolated rat thoracic aorta. Phytomedicine. 2006; 13:651–657.
Article
19. Zhao C, Chae HJ, Kim SH, Cui WS, Lee SW, Jeon JH, Park JK. A new perfusion model for studying erectile function. J Sex Med. 2010; 7:1419–1428.
Article
20. Cui X, Lee SJ, Kim SZ, Kim SH, Cho KW. Effects of pituitary adenylate cyclase activating polypeptide27 on cyclic AMP efflux and atrial dynamics in perfused beating atria. Eur J Pharmacol. 2000; 402:129–137.
Article
21. Kim HK, Bak YO, Choi BR, Zhao C, Lee HJ, Kim CY, Lee SW, Jeon JH, Park JK. The role of the lignan constituents in the effect of Schisandra chinensis fruit extract on penile erection. Phytother Res. 2011; 25:1776–1782.
Article
22. Seok YM, Choi YW, Kim GD, Kim HY, Takuwa Y, Kim IK. Effects of gomisin A on vascular contraction in rat aortic rings. Naunyn Schmiedebergs Arch Pharmacol. 2011; 383:45–56.
Article
23. Park JY, Lee SJ, Yun MR, Seo KW, Bae SS, Park JW, Lee YJ, Shin WJ, Choi YW, Kim CD. Gomisin A from Schisandra chinensis induces endothelium-dependent and direct relaxation in rat thoracic aorta. Planta medica. 2007; 73:1537–1542.
Article
24. McMahon C. Erectile dysfunction. Intern Med J. 2014; 44:18–26.
Article
25. Kandeel FR, Koussa VK, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev. 2001; 22:342–388.
Article
26. Gonzalez-Cadavid NF, Rajfer J. The pleiotropic effects of inducible nitric oxide synthase (iNOS) on the physiology and pathology of penile erection. Curr Pharm Des. 2005; 11:4041–4046.
Article
27. Haas CA, Seftel AD, Razmjouei K, Ganz MB, Hampel N, Ferguson K. Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase. Urology. 1998; 51:516–522.
Article
28. Park JY, Shin HK, Lee YJ, Choi YW, Bae SS, Kim CD. The mechanism of vasorelaxation induced by Schisandra chinensis extract in rat thoracic aorta. J Ethnopharmacol. 2009; 121:69–73.
Article
29. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, Vardi Y. EAU Guidelines on erectile dysfunction: an update. Eur Urol. 2006; 49:806–815.
Article
30. Huang SA, Lie JD. Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction. P T. 2013; 38:407.
31. DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol. 2004; 93:147–153.
Article
32. Wachtel H. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology. 1983; 22:267–272.
Article
33. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev. 1995; 75:725–748.
Article
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr